Ruth Frances Keir runs Cambridge Cognition (AIM: COG), one of the 10 Companies to Watch in 2013/ 2014 according to our latest market report, which develops and commercializes computerised neuropsychological tests used in a variety of healthcare and research settings. She joined the Cambridge Cognition board initially in 2010 as a non-executive director, bringing to it more than 26 years’ experience in research and business development positions in the pharmaceutical industry, as well as a period as Director of her own consultancy business, Archea Ltd.
–> To Learn More and Register, click on 2013 SharpBrains Virtual Summit: September 19–20th, 2013